Literature DB >> 10752652

Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group.

P Boiesen1, P O Bendahl, L Anagnostaki, H Domanski, E Holm, I Idvall, S Johansson, O Ljungberg, A Ringberg, G Ostberg, M Fernö.   

Abstract

Histologic grade, including tubular formations, nuclear grade, and mitotic activity, is a well-documented prognostic factor in breast cancer. In comparison with other prognostic parameters, the evaluation of histologic grade is cheap and can be performed, in principle, in all cases of breast cancer. One possible disadvantage is that the evaluation may vary between different pathological departments. The aim of the present work was therefore to study the reproducibility of the histologic grading system by distributing haematoxylin-erythrosin-stained slides from 93 invasive breast cancers to the seven pathology departments within the southern healthcare region of Sweden. The evaluation was performed blindly and without any knowledge of other clinical parameters. In 31% of the cases the same histologic grade was obtained for all departments. The overall mean kappa was 0.54, indicating a moderate reproducibility. Of the three factors included in histologic grade, the agreement was best for tubular formations and poorest for nuclear grade and mitotic activity. The overall moderate reproducibility should be considered when the clinical usefulness of histologic grading is compared with other prognostic instruments.

Entities:  

Mesh:

Year:  2000        PMID: 10752652     DOI: 10.1080/028418600430950

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  26 in total

1.  Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

Authors:  T J Anderson
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

Review 2.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

3.  Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen.

Authors:  Victor Piana de Andrade; Helenice Gobbi
Journal:  Virchows Arch       Date:  2004-10-08       Impact factor: 4.064

Review 4.  The promise of molecular profiling for cancer identification and treatment.

Authors:  Deanna Cross; James K Burmester
Journal:  Clin Med Res       Date:  2004-08

5.  Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.

Authors:  S Frkovic-Grazio; M Bracko
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

Review 6.  Progress on deep learning in digital pathology of breast cancer: a narrative review.

Authors:  Jingjin Zhu; Mei Liu; Xiru Li
Journal:  Gland Surg       Date:  2022-04

7.  Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.

Authors:  Ossama Tawfik; Bruce F Kimler; Marilyn Davis; Christopher Stasik; Sue-Min Lai; Matthew S Mayo; Fang Fan; John K Donahue; Ivan Damjanov; Patricia Thomas; Carol Connor; William R Jewell; Holly Smith; Carol J Fabian
Journal:  Virchows Arch       Date:  2007-04-26       Impact factor: 4.064

Review 8.  Prognostic value of proliferation in invasive breast cancer: a review.

Authors:  P J van Diest; E van der Wall; J P A Baak
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

9.  Multi-field-of-view framework for distinguishing tumor grade in ER+ breast cancer from entire histopathology slides.

Authors:  Ajay Basavanhally; Shridar Ganesan; Michael Feldman; Natalie Shih; Carolyn Mies; John Tomaszewski; Anant Madabhushi
Journal:  IEEE Trans Biomed Eng       Date:  2013-02-05       Impact factor: 4.538

Review 10.  Breast cancer prognostic classification in the molecular era: the role of histological grade.

Authors:  Emad A Rakha; Jorge S Reis-Filho; Frederick Baehner; David J Dabbs; Thomas Decker; Vincenzo Eusebi; Stephen B Fox; Shu Ichihara; Jocelyne Jacquemier; Sunil R Lakhani; José Palacios; Andrea L Richardson; Stuart J Schnitt; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Sunil Badve; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2010-07-30       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.